LUNG CANCER MEDICINE CONTAINING SRC FAMILY TYROSINE KINASE INHIBITOR FOR INHIBITING VARIANT EGFR DOWNSTREAM SIGNAL AND UTILIZATION THEREOF

摘要

PROBLEM TO BE SOLVED: To provide a medicine for treating lung cancer cells without affecting the normal signal transmission route of receptor type tyrosine kinase, and to provide a method thereof. SOLUTION: This medicine for treating lung cancer having cancer cells expressing variant type EGFR is characterized by containing a Src family tyrosine kinase inhibitor not inhibiting a wild type EGFR tyrosine kinase activity in normal cells. COPYRIGHT: (C)2007,JPO&INPIT